Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Dapas

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Hepatobiliary Surgery and Nutrition|September 10, 2014
Can TIE-2 expressing monocytes represent a novel marker for hepatocellular carcinoma?Barbara Dapas, Mario Grassi, Gabriele Grassi
World Journal of Gastroenterology|August 21, 2015
Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinomaRossella Farra, Mario Grassi, Gabriele Grassi, et al.
Biochimie|August 2, 2005
Aptameric GT oligomers need to be complexed to ethoxylated polyethylenimine as pre-paired duplexes to efficiently exert their cytotoxic activity in human lymphoblastic cancer cellsBruna Scaggiante, Barbara Dapas, Laura Perissin, et al.
The FEBS Journal|May 13, 2006
Interaction of G-rich GT oligonucleotides with nuclear-associated eEF1A is correlated with their antiproliferative effect in haematopoietic human cancer cell linesBruna Scaggiante, Barbara Dapas, Gabriele Grassi, et al.
Hematological Oncology|August 30, 2012
The more basic isoform of eEF1A relates to tumour cell phenotype and is modulated by hyper-proliferative/differentiating stimuli in normal lymphocytes and CCRF-CEM T-lymphoblastsBruna Scaggiante, Barbara Dapas, Gabriele Pozzato, et al.
Expert Opinion on Therapeutic Targets|February 7, 2019
E2F1 as a molecular drug target in ovarian cancerRossella Farra, Barbara Dapas, Mario Grassi, et al.
Antisense & Nucleic Acid Drug Development|September 20, 2002
Increase in therapeutic index of doxorubicin and vinblastine by aptameric oligonucleotide in human T lymphoblastic drug-sensitive and multidrug-resistant cellsBarbara Dapas, Laura Perissin, Carlo Pucillo, et al.
Biomedicines|April 27, 2024
Plasma Circular RNAs as Biomarkers for Breast CancerDomenico Tierno, Gabriele Grassi, Fabrizio Zanconati, et al.
Current Medicinal Chemistry|July 15, 2020
Drugs Repurposing in High-Grade Serous Ovarian CancerManuel Torralba, Rossella Farra, Marianna Maddaloni, et al.
International Journal of Pharmaceutics|December 20, 2016
Rapid and cost-effective xenograft hepatocellular carcinoma model in Zebrafish for drug testingFederica Tonon, Cristina Zennaro, Barbara Dapas, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Hepatobiliary Surgery and Nutrition|September 10, 2014
Can TIE-2 expressing monocytes represent a novel marker for hepatocellular carcinoma?Barbara Dapas, Mario Grassi, Gabriele Grassi
World Journal of Gastroenterology|August 21, 2015
Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinomaRossella Farra, Mario Grassi, Gabriele Grassi, et al.
Biochimie|August 2, 2005
Aptameric GT oligomers need to be complexed to ethoxylated polyethylenimine as pre-paired duplexes to efficiently exert their cytotoxic activity in human lymphoblastic cancer cellsBruna Scaggiante, Barbara Dapas, Laura Perissin, et al.
The FEBS Journal|May 13, 2006
Interaction of G-rich GT oligonucleotides with nuclear-associated eEF1A is correlated with their antiproliferative effect in haematopoietic human cancer cell linesBruna Scaggiante, Barbara Dapas, Gabriele Grassi, et al.
Hematological Oncology|August 30, 2012
The more basic isoform of eEF1A relates to tumour cell phenotype and is modulated by hyper-proliferative/differentiating stimuli in normal lymphocytes and CCRF-CEM T-lymphoblastsBruna Scaggiante, Barbara Dapas, Gabriele Pozzato, et al.
Expert Opinion on Therapeutic Targets|February 7, 2019
E2F1 as a molecular drug target in ovarian cancerRossella Farra, Barbara Dapas, Mario Grassi, et al.
Antisense & Nucleic Acid Drug Development|September 20, 2002
Increase in therapeutic index of doxorubicin and vinblastine by aptameric oligonucleotide in human T lymphoblastic drug-sensitive and multidrug-resistant cellsBarbara Dapas, Laura Perissin, Carlo Pucillo, et al.
Biomedicines|April 27, 2024
Plasma Circular RNAs as Biomarkers for Breast CancerDomenico Tierno, Gabriele Grassi, Fabrizio Zanconati, et al.
Current Medicinal Chemistry|July 15, 2020
Drugs Repurposing in High-Grade Serous Ovarian CancerManuel Torralba, Rossella Farra, Marianna Maddaloni, et al.
International Journal of Pharmaceutics|December 20, 2016
Rapid and cost-effective xenograft hepatocellular carcinoma model in Zebrafish for drug testingFederica Tonon, Cristina Zennaro, Barbara Dapas, et al.
Pageof 6